Price target
Based on analysts projections #ZIVO is expected to experience a price decline over the next year.
The current average ZIVO price target, as estimated by these analysts, is $0.00.
The predictions for the future ZIVO stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for ZIVO.
It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.
ZIVO stock forecasts by analyst
| Analyst / firm | Date | Rating | Price target | Price when posted |
|---|
There are no data to display
ZIVO Bioscience (ZIVO) Fundamentals Checker
Financial metrics are used to evaluate financial stability which helps analysts determine if ZIVO Bioscience is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.
Neutral
Financial Scores
Updated on: 29/11/2023
Altman Z-Score: -93.9
Piotroski Score: 4.0
ESG Score
Updated on: 29/11/2023
Environmental: 56.2
Social: 58.5
Governance: 66.5
Financial Health
Updated on: 29/11/2023
DCF: Strong Buy
ROE: Strong Buy
ROA: Strong Sell
Debt to equity ratio: Strong Sell
Price to earnings ratio: Sell
Price to book ratio: Strong Sell
ZIVO Discounted Cash Flow
Updated on: 29/11/2023
$1.102
Discounted Cash Flow Value
$1.100
Current Price
ZIVO Revenues by Segment
Updated on: 29/11/2023
No available data
Revenue from Contract with Customer, Excluding Assessed Tax
ZIVO Revenues by Region
Updated on: 29/11/2023
No available data
ZIVO Notes Due
Updated on: 29/11/2023
| CIK | Exchange | Title |
|---|
There are no data to display
No social results for ZIVO
ZIVO Bioscience Inc.'s Stock Forecast: Promising Growth in Animal and Human Nutrition Sectors
ZIVO Bioscience Inc. (ZIVO) is a biotechnology company that develops and commercializes natural nutritional ingredients and products for human and animal health. The company uses its proprietary algae technology platform to develop these ingredients, which are rich in nutrients and bioactive compounds. ZIVO's primary focus is on animal nutrition, particularly in the poultry, swine, and dairy industries. The company has... Read more
ZIVO Bioscience: A Promising Player in Biotech Stock Prediction
The biotechnology sector is an exciting and rapidly growing industry within the stock market world. Companies within this sector focus on applying cutting-edge science and technology to develop new medical treatments, therapies, and innovative products for a variety of health conditions. One company that has been generating buzz in the biotechnology sphere is ZIVO Bioscience. With their stock ticker symbol...
Investors who are considering investing in the biotechnology sector often look for strong indicators that may influence stock predictions. In ZIVO's case, they have a robust R&D pipeline that includes more than 50 ongoing research projects. Additionally, notable partnerships with companies such as NutriQuest LLC show promising signs of future growth potential.
Another key contributor when evaluating the overall potential of ZIVO is the favorable regulatory environment in which they operate. The FDA has classified the firm's flagship product line as Generally Recognized as Safe (GRAS), which means there is no required pre-market review or approval needed before they can enter commercial production.
Of course, like with all stock predictions, it's worth mentioning that there are always risks involved with investing in any particular company, regardless of industry or past performance. However, many investors feel optimistic about the future prospects for ZIVO Bioscience as a leading player in the biotech sector.
In conclusion, while no one can fully predict how well any specific company will perform over time, ZIVO Bioscience certainly appears to be making positive strides within both its own R&D pipeline and broader cultural trends toward natural ingredients-based healthcare solutions. For investors interested in this space or seeking out new opportunities for growth-focused firms outside COVID-19 impacted areas - Biotechnology could be an intriguing choice worthy of further exploration!">Read more
Investors who are considering investing in the biotechnology sector often look for strong indicators that may influence stock predictions. In ZIVO's case, they have a robust R&D pipeline that includes more than 50 ongoing research projects. Additionally, notable partnerships with companies such as NutriQuest LLC show promising signs of future growth potential.
Another key contributor when evaluating the overall potential of ZIVO is the favorable regulatory environment in which they operate. The FDA has classified the firm's flagship product line as Generally Recognized as Safe (GRAS), which means there is no required pre-market review or approval needed before they can enter commercial production.
Of course, like with all stock predictions, it's worth mentioning that there are always risks involved with investing in any particular company, regardless of industry or past performance. However, many investors feel optimistic about the future prospects for ZIVO Bioscience as a leading player in the biotech sector.
In conclusion, while no one can fully predict how well any specific company will perform over time, ZIVO Bioscience certainly appears to be making positive strides within both its own R&D pipeline and broader cultural trends toward natural ingredients-based healthcare solutions. For investors interested in this space or seeking out new opportunities for growth-focused firms outside COVID-19 impacted areas - Biotechnology could be an intriguing choice worthy of further exploration!">Read more
ZIVO Bioscience (ZIVO) Social Sentiments
Monitoring bullish and bearish sentiments towards ZIVO Bioscience on Twitter and Stocktwits could help to forecast an upward or downward trend in ZIVO Bioscience stock price.